Engineering polyphenol-based carriers for nucleic acid delivery

Theranostics. 2023 May 21;13(10):3204-3223. doi: 10.7150/thno.81604. eCollection 2023.

Abstract

Gene therapy, an effective medical intervention strategy, is increasingly employed in basic research and clinical practice for promising and unique therapeutic effects for diseases treatment, such as cardiovascular disorders, cancer, neurological pathologies, infectious diseases, and wound healing. However, naked DNA/RNA is readily hydrolyzed by nucleic acid degrading enzymes in the extracellular environment and degraded by lysosomes during intracellular physiological conditions, thus gene transfer must cross complex cellular and tissue barriers to deliver genetic materials into targeted cells and drive efficient activation or inhibition of the proteins. At present, the lack of safe, highly efficient, and non-immunogenic drug carriers is the main drawback of gene therapy. Considering the dense hydroxyl groups on the benzene rings in natural polyphenols that exert a strong affinity to various nucleic acids via hydrogen bonding and hydrophobic interactions, polyphenol-based carriers are promising anchors for gene delivery in which polyphenols serve as the primary building blocks. In this review, the recent progress in polyphenol-assisted gene delivery was summarized, which provided an easily accessible reference for the design of future polyphenol-based gene delivery vectors. Nucleic acids discussed in this review include DNA, short interfering RNAs (siRNA), microRNA (miRNA), double-strand RNA (dsRNA), and messenger RNA (mRNA).

Keywords: EGCG; RNA; gene therapy; nucleic acid; polyphenols.

Publication types

  • Review

MeSH terms

  • DNA / metabolism
  • Gene Transfer Techniques
  • Genetic Therapy
  • Nucleic Acids*
  • RNA, Small Interfering / genetics

Substances

  • Nucleic Acids
  • DNA
  • RNA, Small Interfering